INTERTRUST-GROUP
Intertrust N.V. (“Intertrust” or “Company”) [Euronext: INTER], a world leader in providing specialised administration services to clients in over 30 jurisdictions, today reveals a fresh new logo and its new partnership with Kiva, an international non-profit whose mission is to expand financial access to help underserved communities improve their lives.
The rebrand ushers in a new era for the company and reflects its growth and acquisitions in recent years. It also completes the full integration of Viteos following its mid-2019 acquisition. An updated look reflects the company’s ability to keep clients one step ahead through a combination of its local, expert knowledge and innovative, proprietary technology. Intertrust Group’s focus on bespoke corporate, fund, capital market and private wealth services enables its clients to invest, grow and thrive anywhere in the world. And it is with this in mind that Intertrust Group has decided to announce a strategic partnership with Kiva, a non-profit that is dedicated to unlocking financial access to help underserved communities invest in their future.
Stephanie Miller, CEO of Intertrust Group, said: “The community engagement and charitable efforts of our employees is a hallmark of Intertrust Group. Our partnership with Kiva will put our employees in the driver’s seat and make corporate philanthropy a very personal experience, allowing us to continue to make a meaningful impact on communities all around the world. I can think of no better way to mark our special day.”
Sarah Marchal Murray, Chief Strategic Partnerships Officer of Kiva added, “Kiva envisions a financially inclusive world where all people hold the power to improve their lives. I believe this collaboration with Intertrust Group will show what’s possible when a company and its employees are committed to doing good and helping others to invest, grow and thrive.”
***ENDS***
About Intertrust Group
At Intertrust Group our 4,000 employees are dedicated to providing world-leading, specialised administration services to clients in over 30 jurisdictions. This is amplified by the support we offer across our approved partner network which covers a further 100+ jurisdictions. Our focus on bespoke corporate, fund, capital market and private wealth services enables our clients to invest, grow and thrive anywhere in the world. Sitting at the heart of international business, our local, expert knowledge and innovative, proprietary technology combine to deliver a compelling proposition – all of which keeps our clients one step ahead.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201019005272/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Regula Contributes Industry Expertise to Two New Analyst Reports on Document Fraud and Identity Verification Trends6.1.2026 14:00:00 CET | Press release
Regula, a global developer of identity verification solutions and forensic devices, has contributed its expert knowledge to two new analyst reports by Forrester Research. With more than 30 years of experience in forensic document examination and decades of collaboration with border agencies worldwide, Regula contributed as a domain expert in document forensics and identity verification. Contribution to “The State of Document Fraud Management” This report, authored by Andras Cser, VP Principal Analyst at Forrester Research,examines the growing need to verify physical non-identity documents in digital onboarding. These documents include bank statements, telecom bills, utility bills, and receipts. Their verification is now as important as physical identity document verification, because organizations increasingly rely on both document types to onboard individuals and businesses. Regula was interviewed as one of the expert contributors. A significant portion of the analysis is based on mat
Loomis Sayles Proudly Celebrates 100 Years of Client Commitment and Investment Excellence6.1.2026 13:00:00 CET | Press release
Loomis, Sayles & Company, the investment manager with $425 billion in assets under managementi, proudly marks its centennial year, celebrating a legacy of independent thinking and a relentless commitment to helping clients achieve their goals. Founded in January 1926, Loomis Sayles has grown to serving over 1,000 institutional clients in 28 countries offering differentiated investment solutions across fixed income, equity and alternative markets. “Reaching a century is rare. Doing so with the continued trust of clients and partners around the world is exceptional and we are honored to celebrate with all of them,” said Kevin Charleston, Chairman and Chief Executive Officer of Loomis Sayles. “As Loomis Sayles celebrates its 100th anniversary, we look ahead with gratitude for the opportunity to continue growing and innovating alongside those we serve.” A Legacy of Client Commitment and High-Conviction Analysis Throughout its history, Loomis Sayles has remained steadfast in its mission: to
Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP3606.1.2026 12:30:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into its seventh strategic collaboration, with Radial Health, Inc., a growing national network of interventional psychiatry practices leveraging technology and operations expertise to optimize models of care delivery. This collaboration will further help to inform the development of scalable delivery models for investigational COMP360 psilocybin treatment, if FDA approved. The agreement with Radial expands the set of collaborations that Compass has established representing a broad spectrum of settings where people living with mental health conditions receive their care in the United States. Radial is building a national network of clinics across the U.S., delivering interventional, evidence-based treatments for mental health conditions. The co-founders have a mission-driven background in designing customer-centric care and bui
Hitachi Launches Expanded HMAX Solutions Accelerating Social Innovation Globally Across Industries6.1.2026 11:30:00 CET | Press release
A Suite of Solutions Leveraging Advanced AI with Company’s Deep Domain Knowledge of Social Infrastructure Hitachi, Ltd. (TSE:6501, "Hitachi") today introduced HMAX by Hitachi at CES 2026. HMAX by Hitachi is a suite of next-generation solutions that brings the power of AI to social infrastructure. By harnessing vast data from physical and digital assets, integrating advanced AI, and applying Hitachi’s unmatched domain expertise, HMAX tackles the most complex social infrastructure challenges—maximizing outcomes and value for our clients and society. These solutions are derived from the formalized HMAX design principles, integrating a dynamic collection of advanced technologies and a robust partner ecosystem that helps elevate end-system reliability and performance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106885363/en/ HMAX by Hitachi: the suite of next-generation solutions that brings the power of AI to social infras
Pandorum Technologies and Nucelion Therapeutics Announce Strategic Collaboration to Manufacture Exosome-Based Tissue Regenerative Therapy for Ocular Diseases in APAC Markets6.1.2026 11:00:00 CET | Press release
Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmable tissue regeneration, today announced a strategic collaboration with Hyderabad based Nucelion Therapeutics, a specialized contract research, development and manufacturing organization (CRDMO), to expand manufacturing capabilities for Pandorum’s exosome-based therapeutic platform across the Asia-Pacific (APAC) region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106214233/en/ This strategic collaboration aligns with a shared vision, as Pandorum’s asset(s) progress toward clinical trials. By leveraging Nucelion Therapeutics’ manufacturing capabilities, the partnership supports regional supply and regulatory readiness, marking a strategic step forward. Furthermore, it reaffirms India’s growing capability to develop and manufacture cutting-edge biologic therapies for the world. “Pandorum is building a gl
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom